Antipodean Advisors LLC Exact Sciences Corp Transaction History

Antipodean Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $271,110 - $367,470	-3,000 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $268,530 - $354,120	3,000 New	3,000 $354,000
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $3.03 Million - $4.46 Million	-54,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $8.64 Million - $14.4 Million	-179,000 Reduced 76.82%	54,000 $4.26 Million
Q2 2018 Aug 14, 2018	SELL	$37.84 - $69.96 $126,612 - $234,086	-3,346 Reduced 1.42%	233,000 $13.9 Million

Q1 2018 May 15, 2018	SELL	$39.82 - $57.53 $13.6 Million - $19.6 Million	-341,000 Reduced 59.06%	236,346 $9.53 Million
Q3 2017 Nov 14, 2017	BUY	$37.05 - $47.12 $21.4 Million - $27.2 Million	577,346	577,346 $27.2 Million

699

160M

5.84M

2.58M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.89B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Antipodean Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Antipodean Advisors LLC with notifications on news.